| Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment WB Fang, M Yao, G Brummer, D Acevedo, N Alhakamy, C Berkland, ... Oncotarget 7 (31), 49349, 2016 | 114 | 2016 |
| Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease SK Bhattamisra, AT Shak, LW Xi, NH Safian, H Choudhury, WM Lim, ... International journal of pharmaceutics 579, 119148, 2020 | 113 | 2020 |
| Fabrication, optimization, and evaluation of rotigotine-loaded chitosan nanoparticles for nose-to-brain delivery AS Tzeyung, S Md, SK Bhattamisra, T Madheswaran, NA Alhakamy, ... Pharmaceutics 11 (1), 26, 2019 | 106 | 2019 |
| Noncovalently associated cell-penetrating peptides for gene delivery applications NA Alhakamy, AS Nigatu, CJ Berkland, JD Ramsey Therapeutic delivery 4 (6), 741-757, 2013 | 82 | 2013 |
| Formulation design, statistical optimization, and in vitro evaluation of a naringenin nanoemulsion to enhance apoptotic activity in A549 lung cancer cells S Md, NA Alhakamy, HM Aldawsari, M Husain, S Kotta, ST Abdullah, ... Pharmaceuticals 13 (7), 152, 2020 | 77 | 2020 |
| Formulation development and evaluation of rotigotine mucoadhesive nanoemulsion for intranasal delivery H Choudhury, NFB Zakaria, PAB Tilang, AS Tzeyung, M Pandey, ... Journal of Drug Delivery Science and Technology 54, 101301, 2019 | 71 | 2019 |
| The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer S Singh, A Numan, B Maddiboyina, S Arora, Y Riadi, S Md, NA Alhakamy, ... Drug discovery today 26 (7), 1721-1727, 2021 | 70 | 2021 |
| Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes NA Alhakamy, CJ Berkland Molecular pharmaceutics 10 (5), 1940-1948, 2013 | 66 | 2013 |
| Preparation and characterization of chitosan coated plga nanoparticles of resveratrol: Improved stability, antioxidant and apoptotic activities in H1299 lung cancer cells HM Aldawsari, NA Alhakamy, R Padder, M Husain, S Md Coatings 10 (5), 439, 2020 | 65 | 2020 |
| Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer MH Sultan, SS Moni, OA Madkhali, MA Bakkari, S Alshahrani, ... Scientific reports 12 (1), 468, 2022 | 58 | 2022 |
| Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy GS Bhagwat, RB Athawale, RP Gude, S Md, NA Alhakamy, UA Fahmy, ... Frontiers in Pharmacology 11, 614290, 2020 | 58 | 2020 |
| Promising Antibiofilm Agents: Recent Breakthrough against Biofilm Producing Methicillin-Resistant Staphylococcus aureus MI Abd El-Hamid, E Y. El-Naenaeey, T M kandeel, WAH Hegazy, ... Antibiotics 9 (10), 667, 2020 | 57 | 2020 |
| Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing in Pseudomonas aeruginosa WAH Hegazy, MT Khayat, TS Ibrahim, MS Nassar, MA Bakhrebah, ... Microorganisms 8 (9), 1285, 2020 | 57 | 2020 |
| Neuroprotective and antioxidant effect of naringenin-loaded nanoparticles for nose-to-brain delivery S Md, NA Alhakamy, HM Aldawsari, HZ Asfour Brain sciences 9 (10), 275, 2019 | 53 | 2019 |
| The era of gene therapy: From preclinical development to clinical application NA Alhakamy, DT Curiel, CJ Berkland Drug discovery today 26 (7), 1602-1619, 2021 | 50 | 2021 |
| Charge type, charge spacing, and hydrophobicity of arginine-rich cell-penetrating peptides dictate gene transfection NA Alhakamy, P Dhar, CJ Berkland Molecular pharmaceutics 13 (3), 1047-1057, 2016 | 50 | 2016 |
| Improved Analgesic and Anti‐Inflammatory Effect of Diclofenac Sodium by Topical Nanoemulgel: Formulation Development—In Vitro and In Vivo Studies S Md, NA Alhakamy, HM Aldawsari, S Kotta, J Ahmad, S Akhter, ... Journal of chemistry 2020 (1), 4071818, 2020 | 49 | 2020 |
| Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and … Ameeduzzafar, NK Alruwaili, SS Imam, NH Alotaibi, NA Alhakamy, ... AAPS PharmSciTech 21, 1-16, 2020 | 47 | 2020 |
| Exploring the potential of carbon dots to combat COVID-19 S Kotta, HM Aldawsari, SM Badr-Eldin, NA Alhakamy, S Md, AB Nair, ... Frontiers in Molecular Biosciences 7, 616575, 2020 | 46 | 2020 |
| Recent advances in pharmaceutical cocrystals: From bench to market R Kumar Bandaru, SR Rout, G Kenguva, B Gorain, NA Alhakamy, ... Frontiers in Pharmacology 12, 780582, 2021 | 45 | 2021 |
Hibah AldawsariAssociate Professor of Pharmaceutics在 kau.edu.sa 的电子邮件经过验证
